Key result
Cinnamon extract treatment for six weeks reduced fasting blood sugar, cardiac injury markers, inflammation, and fibrosis in diabetic rats.
Why the study?
Diabetic cardiomyopathy requires new drug therapies, and while cinnamon has known lipid-lowering, antioxidative, and anti-inflammatory effects, the extent of its cardioprotective effects in diabetes remained undetermined.
Does cinnamon extract attenuate diabetic cardiomyopathy in diabetic rats?
Does cinnamon extract attenuate diabetic cardiomyopathy in diabetic rats?
Cinnamon extract attenuates diabetic cardiomyopathy in a rat model by reducing inflammation, fibrosis, and oxidative stress.
Answers are grounded in this paper and cite their sources.
Cinnamon attenuated DCM in rats; leaves open whether anti-fibro-inflammatory effects translate to patients.
Diabetic cardiomyopathy (DCM) is a chronic complication of diabetes that emphasizes the urgency of developing new drug therapies. With an illustrious history in traditional medicine to improve diabetes, cinnamon has been shown to possess blood lipids lowering effects and antioxidative and anti-inflammatory properties. However, the extent to which it protects the diabetic heart has yet to be determined. Forty-eight rats were administered in the study and grouped as: control; diabetic; diabetic rats given 100, 200, or 400 mg/kg cinnamon extract, metformin (300 mg/kg), valsartan (30 mg/kg), or met/val (combination of both drugs), via gavage for six weeks. Fasting blood sugar (FBS) and markers of cardiac injury including creatine kinase-muscle/brain (CK-MB), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) were evaluated in blood samples. Malondialdehyde (MDA) levels, the total contents of thiol, superoxide dismutase (SOD), and catalase (CAT) activities were measured. Histopathology study and gene expression measurement of angiotensin II type 1 receptor (AT1), atrial natriuretic peptide (ANP), beta-myosin heavy chain (β-MHC), and brain natriuretic peptide (BNP) were done on cardiac tissue. FBS and cardiac enzyme indicators were reduced in all treated groups. A reduction in MDA level and enhancement in thiol content alongside with increase of SOD and CAT activities were observed in extract groups. The decrease of inflammation and fibrosis was obvious in treated groups, notably in the high-dose extract group. Furthermore, all treated diabetic groups showed a lowering trend in AT1, ANP, β-MHC, and BNP gene expression. Cinnamon extract, in addition to its hypoglycemic and antioxidant properties, can prevent diabetic heart damage by alleviating cardiac inflammation and fibrosis. PRACTICAL APPLICATIONS: This study found that cinnamon extract might protect diabetic heart damage by reducing inflammation and fibrosis in cardiac tissue, in addition to lowering blood glucose levels and increasing antioxidant activity. Our data imply that including cinnamon in diabetic participants' diets may help to reduce risk factors of cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Farazandeh et al. (2022) studied Diabetic cardiomyopathy (n=48). Cinnamon extract vs. control, diabetic, metformin, valsartan, or met/val combination was evaluated on Fasting blood sugar, cardiac injury markers, oxidative stress markers, histopathology, and gene expression. Cinnamon extract treatment for six weeks reduced fasting blood sugar, cardiac injury markers, inflammation, and fibrosis in diabetic rats.
Synapse has enriched 10 related papers. Consider them for comparative context: